Clinical trial · Interventional
A Randomized Controlled Study on the Improvement of Medical Experience for Patients With Radiation-induced Oropharyngeal Mucositis Based on the RIS System of the Internet of Things
NCT07126457CI-TRIAL-00093788not yet recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study is a researcher-initiated, multi-center, prospective, two-arm interventional randomized controlled study across the country. It aims to explore whether an Internet of Things-based RIS system can enhance the medical experience of patients with radiation-induced oropharyngeal mucositis during the diagnosis and treatment process among head and neck cancer patients undergoing radiotherapy.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Head and Neck Cancer | Malignant Head and Neck Neoplasm | ALIAS | 0.90 |
| Radiation-Induced Mucositis | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| RIS system | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- experimental group
- description
- Use the RIS system
- interventionNames
- Other: RIS system
- type
- NO_INTERVENTION
- label
- control group
- description
- Do not use the ris system
Primary outcomes (1)
- measure
- the satisfaction of patients
- timeFrame
- Through study completion, up to 3 years
- description
- We use the patient satisfaction scale designed by us for the information age to assess patients' satisfaction during the diagnosis and treatment period.
Secondary outcomes (4)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: 1. Voluntarily sign the informed consent form; 2. Reached the age of 18 on the date of signing the informed consent form, and under the age of 65; 3. Patients diagnosed with head and neck tumors and receiving radiotherapy as per the 2017 WHO standards and guidelines. 4. According to the doctor's assessment, patients may experience radiation-induced oropharyngeal mucositis during radiotherapy. Exclusion Criteria: * Have other uncontrolled serious diseases, such as unstable heart diseases requiring treatment, poorly controlled diabetes (fasting blood sugar \> 1.5 times the upper limit of the normal value), mental disorders, and a severe history of allergies.
References
Publications (0)
Data not yet available
No reference posted for this study.